1 publication

• Published Subscription Original Research 29 Mar 2025

  Bedaquiline: An In-Depth Exploration into Its Antitubercular Significance

  By Subha Deepa, D. Visagaperumal, Vineeth Chandy

  Abstract: Tuberculosis is still a leading infectious disease and a major threat to public health. Although there has been a slow decrease in the incidence over years, its “hard to kill nature” is responsible of about 2 million deaths in HIV infected individuals annually. Bedaquiline, a Diaryl-Quinoline drug was fast-track approved as an orphan drug to combat drug resistance. It shows potent activity against Mycobacterium tuberculosis by interfering with the production …

  Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 12, Issue 2, 2025 · pp. 06–14 Read article →